Trump vaccine plan, "October Surprise" reappears?

2020-09-05

President Trump said at a rally in Pennsylvania on September 3 that a new coronavirus vaccine might be available next month. Trump pointed out that the three vaccines are in the final stages of clinical trials. Trump said at a rally in Latrobe, Pennsylvania: “According to the speed of action, we can still produce a safe and effective vaccine in the record time we are talking about. In my opinion, it will be before the end of the year. Delivered, but in fact it may even be delivered before the end of October.”

According to the New York Times, on August 27, the Centers for Disease Control and Prevention issued a notice to health bureau officials in 50 states and 5 first-tier cities, asking all localities to prepare for the new crown vaccine in late October or early November. The first batch of vaccinators include medical staff, law enforcement personnel and high-risk groups.

At present, the vaccines developed by the American biotechnology companies Modena and Pfizer, and the British Astrazeneca (Astrazeneca) have all undergone the third phase of clinical trials in the United States, the human test phase.

Operation Warp Speed is a plan initiated by the U.S. federal government to develop a vaccine to prevent the continued spread of warmth virus in the United States. Trump said that this schedule (before the end of October) has nothing to do with the election, but he said it was good because they wanted to save people.

At the rally, Trump specifically mentioned Pfizer (Pfizer) pharmaceutical company, the company’s vaccine has entered Phase III trials, Trump said that Pfizer expects to obtain the results of ongoing trials in the next few weeks. In addition, two other vaccines, Moderna and AstraZeneca, currently in the United States, have also entered phase III trials.

Should people who are used to President Trump’s nonsense believe this October surprise?

U.S. health experts worry that the vaccine will be released before the election. Anthony Fauci, director of the National Institute of Allergy and Infectious Diseases (NIAID), said on September 3 that, as many experts believe, regarding the approval of the new coronavirus pneumonia (COVID-19) vaccine in October, this is not It may happen, but it is not impossible.

In an interview with CNN on the 3rd, Fauci stated that, as experts believe, it is unlikely that the vaccine will be approved in October rather than November and December, but this is not entirely impossible. Thing. He said: “I will assume, and I am pretty sure that this will be the case. Unless the vaccine is really safe and effective, it will not be approved for the American public (use).”

Francis Collins, president of the National Institutes of Health, also said that it is “unlikely” that the new coronavirus vaccine will be ready in October. In his opinion, we can prepare for this, but we must remember this possibility. Very small.

With the increasingly fierce competition in the U.S. election, Trump has recently been urging the speed of new crown vaccine trials and approvals. US Food and Drug Administration Director Stephen Hahn also recently stated that the US new crown vaccine may be approved and urgently before the trial is completed. Authorized to use, some health experts believe that the country’s vaccine is likely to be released prematurely due to some “political pressure”, and the deadline of November 1 is just two days before the US election.

The U.S. election has always had the term “October Surprise”, which means that in the last month or few weeks before the election, there will be events deliberately manufactured, exposed or induced by non-external forces that can affect the election, such as the economic problems in 2008 and 2012 The disaster response bonus points for the year and the fierce materials for 2016 are frequently released.

The U.S. Centers for Disease Control urges states to prepare for mass distribution of vaccines before the election, which has aroused people’s vigilance against Trump’s “October Surprise”. American infectious disease expert Michael Osterholm is worried that the approval of the vaccine before the election will reproduce the “October Surprise”. Although everyone expects a safe and effective vaccine, the experimental data must be clear and convincing.

You may like: